Clinical epidemiology of gallbladder cancer in North-Central India and association of immunological markers, NLR, MLR and PLR in the diagnostic/prognostic prediction of GBC

Barbhuiya M.A., Singh T.D., Poojary S.S., Gupta S., Kakkar M., Shrivastav B.R., et al. Gallbladder cancer incidence in Gwalior district of India: five year trend based on the registry of a regional cancer center. In: Indian J. Cancer. 2015. Hundal R., Shaffer E.A. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014. Dutta U., N. Bush, D. Kalsi, P. Popli, V.K. Kapoor: Epidemiology of gallbladder cancer in India. Chin. Clin. Oncol.2019. Malhotra R.K., N. Manoharan, N.K. Shukla G.K. Rath: Gallbladder cancer incidence in Delhi urban: a 25-year trend analysis. Indian J. Cancer. (2017). Krishnatreya M.: Gall bladder cancer in Delhi-some thoughts. Indian J. Cancer (2019). Shah D., G.K. Makharia, U.C. Ghoshal, S. Varma, V. Ahuja, S. Hutfless: Burden of gastrointestinal and liver diseases in India, 1990-2016. Indian J. Gastroenterol. (2018). Rizzo A., Ricci A.D., Brandi G. Recent advances of immunotherapy for biliary tract cancer. Expert Rev Gastroenterol Hepatol. 2021. Azizi A.A., Lamarca A., McNamara M.G., Valle J.W.: Chemotherapy for advanced gallbladder cancer (GBC): a systematic review and meta-analysis. Crit. Rev. Oncol. Hematol.. 2020. Rizzo A., Brandi G.: Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer. Expert Rev Gastroenterol Hepatol. 2021. Rizzo A., Ricci A.D., Brandi G.: Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary tract cancer. Expert Opin. Investig. Drugs. 2021. Tao Z., Li S.X., Cui X., Huang Y., Zhu S., Wang Y., et al. The prognostic value of preoperative inflammatory indexes in gallbladder carcinoma with hepatic involvement. Cancer Biomarkers. 2018. Cassatella M.A., Östberg N.K., Tamassia N., Soehnlein O.: Biological Roles of Neutrophil-Derived Granule Proteins and Cytokines. Trends Immunol.. 2019. Zhu S., Yang J., Cui X., Zhao Y., Tao Z., Xia F., et al. Preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of clinical outcome in patients with gallbladder cancer. Sci. Rep.. 2019. Barbhuiya M.A., Singh T.D., Gupta S., Kakkar M., Shrivastav B.R., Tiwari P.K. Incidence of gall bladder cancer in rural and semi-urban population of north central India: a first insight. Internet J Epidemiol. 2012. Phadke P.R., Mhatre S.S., Budukh A.M., Dikshit R.P. Trends in gallbladder cancer incidence in the high-and low-risk regions of India. Indian J Med Paediatr Oncol. 2019. Madhawi R., Pandey A., Raj S., Mandal M., Devi S., Sinha P., et al. Geographical pattern of carcinoma gallbladder in Bihar and its association with river Ganges and arsenic levels: retrospective individual consecutive patient data from Regional Cancer Centre. South Asian J Cancer. 2018. Park H.S., Park J.S., Chun Y.J., Roh Y.H., Moon J., Chon H.J., et al. Prognostic factors and scoring model for survival in Metastatic biliary tract cancer. Cancer Res. Treat.. 2017. Lee D.W., Im S.A., Kim Y.J., Yang Y., Rhee J., Na I Il, et al. CA19-9 or CEA decline after the first cycle of treatment predicts survival in advanced biliary tract cancer patients treated with S-1 and cisplatin chemotherapy. Cancer Res. Treat.. 2017. Y. Zhang, C. Jiang, J. Li, J. Sun, X. Qu. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Clin. Transl. Oncol.. 2015. Mady, 2020, Neutrophil to lymphocyte ratio as a prognostic marker in metastatic gallbladder cancer, HPB, 22, 1490, 10.1016/j.hpb.2020.02.002 Zhang Y., Jiang C., Li J., Sun J., Qu X. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Clin. Transl. Oncol.. 2015. Beal E.W., Wei L., Ethun C.G., Black S.M., Dillhoff M., Salem A., et al. Elevated NLR in gallbladder cancer and cholangiocarcinoma – making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium. HPB. 2016. McNamara M.G., Templeton A.J., Maganti M., Walter T., Horgan A.M., McKeever L., et al. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer. Eur. J. Cancer. 2014. Szkandera J., Absenger G., Liegl-Atzwanger B., Pichler M., Stotz M., Samonigg H., et al. Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients. Br. J. Cancer. 2013. Liu F., Hu H.J., Ma W.J., Yang Q., Wang J.K., Li F.Y. Prognostic significance of neutrophil-lymphocyte ratio and carbohydrate antigen 19-9 in patients with gallbladder carcinoma. Medicine (Baltimore).. 2019. Zhu S., Yang J., Cui X., Zhao Y., Tao Z., Xia F., et al. Preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of clinical outcome in patients with gallbladder cancer. Sci Rep. 2019. Kang M.H., Go S.I., Song H.N., Lee A., Kim S.H., Kang J.H., et al. The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer. Br. J. Cancer. 2014. Deng Q., He B., Liu X., Yue J., Ying H., Pan Y., et al. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J. Transl. Med.. 2015. Feng J.F., Huang Y., Chen Q.X. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol. 2014. Giese M.A., Hind L.E., Huttenlocher A. Neutrophil plasticity in the tumor microenvironment. Blood. 2019. Muñoz L.E., Boeltz S., Bilyy R., Schauer C., Mahajan A., Widulin N., et al. Neutrophil Extracellular Traps Initiate Gallstone Formation. Immunity. 2019. You M.S., Ryu J.K., Choi Y.H., Choi J.H., Huh G., Paik W.H., et al. Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin. BMC Cancer. 2019. Gay L.J., Felding-Habermann B. Contribution of platelets to tumour metastasis. Nature Reviews Cancer. 2011. Pang Q., Zhang L.Q., Wang R.T., Bi J Bin, Zhang J.Y., Qu K., et al. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma. World J. Gastroenterol.. 2015. Zhou X., Du Y., Huang Z., Xu J., Qiu T., Wang J., et al. Prognostic value of PLR in various cancers: a meta-analysis. PLoS One. 2014. Templeton A.J., McNamara M.G., Šeruga B., Vera-Badillo F.E., Aneja P., Ocaña A., et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl. Cancer Inst.. 2014. Buergy D., Wenz F., Groden C., Brockmann M.A. Tumor-platelet interaction in solid tumors. International Journal of Cancer. 2012. Zhang M., Huang X.Z., Song Y.X., Gao P., Sun J.X., Wang Z.N. High Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer: a Meta-Analysis. Biomed. Res. Int.. 2017. Wang J., Zhou X., He Y., Chen X., Liu N., Ding Z., et al. Prognostic role of platelet to lymphocyte ratio in prostate cancer A meta-analysis. Medicine (United States). 2018. Cho M.S., Bottsford-Miller J., Vasquez H.G., Stone R., Zand B., Kroll M.H., et al. Platelets increase the proliferation of ovarian cancer cells. Blood. 2012. Choi Y.H., Lee J.W., Lee S.H., Choi J.H., Kang J., Lee B.S., et al. A high monocyte-to-lymphocyte ratio predicts poor prognosis in patients with advanced gallbladder cancer receiving chemotherapy. Cancer Epidemiol. Biomarkers Prev.. 2019. Xu W., Wu X., Wang X., Yu S., Xu G., Xiong J., et al. Prognostic significance of the preoperative lymphocyte to monocyte ratio in patients with gallbladder carcinoma. Cancer Manag Res. 2020. Yang Y.T., Jiang J.H., Yang H.J., Wu Z.J., Xiao Z.M., Xiang B De. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection. Sci. Rep.. 2018. Chen H., Z. Huang, B. Sun, A. Wang, Y. Wang, H. Shi, et al.: The predictive value of systemic immune inflammation index for postoperative survival of gallbladder carcinoma patients. J. Surg. Oncol. (2021).